29.01.2013
- Eli Lilly said on Tuesday that fourth-quarter profit fell as competition from generic drugs, particularly for its once top-selling schizophrenia drug Zyprexa, drove revenue lower...
29.01.2013
- Celanese, a global technology and specialty materials company, today reported fourth quarter 2012 adjusted earnings per share of $0.67, a 16% increase over the prior year period...
26.01.2013
- What a difference a year makes for Procter & Gamble and CEO Bob McDonald. Last February, he unveiled a $10 billion restructuring including thousands of job cuts after the world's...
25.01.2013
- Honeywell International posted fourth-quarter earnings just above Wall Street estimates, reflecting the diversified U.S. manufacturer's campaign to boost profit margins in the face...
24.01.2013
- Medical device and bioscience company Baxter International reported higher quarterly earnings on Thursday and forecast sales growth of 10% for 2013. Fourth-quarter sales were...
24.01.2013
- Amgen on Wednesday projected revenue for 2013 that exceeds Wall Street estimates and said it was on track to deliver on its 2015 forecasts well ahead of schedule. The world's...
24.01.2013
- AbbVie, the new branded pharmaceuticals company spun off by Abbott Laboratories, is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other products...
24.01.2013
- Industrial gas suppliers Praxair and Air Products and Chemicals expect their order backlog to prop up results this year despite weak economic growth in most of their markets. Air...
